Clinical Trials · NCT05107219
GCC Agonist Signal in the Small Intestine
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- University of Wisconsin, Madison
- Enrollment
- 43
- Start date
- Nov 2022
- Locations
- 4 sites, United States
- Primary endpoint
- Cyclic guanosine monophosphate (cGMP) levels